Abstract
Hypereosinophilic syndrome (HES) is a rare cause of recurrent ischemic stroke and the underlying pathogenesis is heterogeneous. Herein, we describe a gentleman presenting with recurrent strokes due to idiopathic HES for 3 years, with a dramatic response to Imatinib.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
